Itraconazolo Mylan Generics (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, preventing the synthesis of ergosterol, an essential component of the fungal cell membrane. This disruption weakens the membrane, leading to increased permeability and ultimately causing fungal cell death.

The specific dose of Itraconazolo Mylan Generics is determined by the prescribing clinician based on the type and severity of the infection, patient age, weight, liver function, and other clinical factors. Patients should follow the exact dosing instructions provided by their healthcare provider.

Safety data for itraconazole in pregnancy and lactation are limited. The medication should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their doctor.

To request Itraconazolo Mylan Generics, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Itraconazole belongs to the azole class, which inhibits ergosterol synthesis. Compared with polyenes such as amphotericin B, azoles are oral, have a broader spectrum against many dermatophytes and dimorphic fungi, and generally have a more favorable safety profile, though they may interact with CYP3A4‑metabolized drugs.

Itraconazolo Mylan Generics should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain potency and stability throughout its shelf life.

The medication is taken orally, typically with food or a full glass of water to improve absorption. Patients should swallow the tablet or capsule whole and avoid crushing or chewing unless specifically instructed by a healthcare professional.

Serious risks include hepatotoxicity, which may present as elevated liver enzymes or liver injury, severe skin reactions such as Stevens‑Johnson syndrome, and worsening heart failure in susceptible individuals. Patients should be monitored regularly for signs of liver dysfunction, skin changes, and cardiac symptoms.

Itraconazolo Mylan Generics is contraindicated in patients with known hypersensitivity to itraconazole or any azole antifungal, and in individuals with severe heart failure (NYHA class III/IV). Caution is also advised for patients with significant liver disease or those taking medications that strongly induce CYP3A4.